22 patent applications, 3 granted patents (US, Europe) in 4 patent families
22 patent applications, 3 granted patents (US, Europe) in 4 patent families
Intellectual Property
Twain has a rich and deep patent portfolio covering the initial concepts underpinning its agonistic antibody approach, together with a series of patent families covering the development of the TRON product.
Broad Claims covering IL2 agonistic bispecific antibodies & ‘TRON1’ family Sequences
Granted in US and Europe. Also filed in 10 other countries
Specific claims covering the ‘TRON2’ family sequences
Filed in US, Europe, China, Japan & Singapore